The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Acadia Healthcare Company Inc

Nasdaq: ACHC
Last

(U.S.) $58.96

Today's change-0.76 -1.27%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

Acadia Healthcare Company Inc

Nasdaq: ACHC
Last

(U.S.) $58.96

Today's change-0.76 -1.27%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Acadia Healthcare Company Inc down (U.S.)$0.76

Acadia Healthcare Company Inc closed lower Friday, dropping (U.S.)$0.76 or 1.27% to (U.S.)$58.96. Over the last five days, shares have lost 3.39% and are down 5.60% for the last year to date. This security has outperformed the S&P 500 by 5.23% during the last year.

Key company metrics

  • Open(U.S.) $60.11
  • Previous close(U.S.) $59.72
  • High(U.S.) $60.69
  • Low(U.S.) $57.85
  • Bid / Ask-- / --
  • YTD % change-5.60%
  • Volume762,698
  • Average volume (10-day)792,170
  • Average volume (1-month)1,085,019
  • Average volume (3-month)869,439
  • 52-week range(U.S.) $54.41 to (U.S.) $85.62
  • Beta0.83
  • Trailing P/E39.13×
  • P/E 1 year forward26.60×
  • Forward PEG0.99×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.51
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.26%

Based on its net profit margin of 6.26%, Acadia Healthcare Company Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue480454366295
Total other revenue--------
Total revenue480454366295
Gross profit--------
Total cost of revenue--------
Total operating expense409375322245
Selling / general / administrative319302250200
Research & development--------
Depreciation / amortization17151311
Interest expense (income), net operating--------
Unusual expense (income)167183
Other operating expenses, total57514131
Operating income70784350
Interest income (expense), net non-operating-28-28-22-15
Gain (loss) on sale of assets--------
Other--------
Income before tax42492135
Income after tax29341522
Income tax, total1316713
Net income30341522
Total adjustments to net income--------
Net income before extra. items29341522
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items29341522
Inc. avail. to common incl. extra. items30341522
Diluted net income30341522
Dilution adjustment--------
Diluted weighted average shares71696360
Diluted EPS excluding extraordinary itemsvalue per share0.410.490.230.37
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.560.560.430.40